A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
NCT06747949
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
844
Enrollment
INDUSTRY
Sponsor class
Conditions
Sjögren's Syndrome
Interventions
DRUG:
Dazodalibep
Sponsor
Amgen